Skip to content
value.today

Pengqi Technology Development

600614.SSUnlisted company
$387 Mlast known market cap, Jan 2020 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

More about Pengqi Technology Development

Acquisitions and changes
No longer listed: the company announced the end of its listing on the Shanghai Stock Exchange on 25 May 2021 ("鹏起科技发展股份有限公司关于公司股票终止上市的公告", CNINFO), and CNINFO no longer serves its profile.

Market cap history

Not enough history yet.

CompanyMarket capP/ENet marginRev. growth
Pengqi Technology Development🇨🇳$387 M———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
UnitedHealth Group Incorporated🇺🇸$367.7 B23.1×3.5%+11.8%
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 1, 2020 (last known)
Profile updated:
Nov 16, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Pengqi Technology Development? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Pengqi Technology Development's ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Pengqi Technology Development? Suggest a correction